Embryonic and induced pluripotent stem cell differentiation as a tool in neurobiology

Biotechnology Journal

Volumn 7, Issue 9, 2012, Pages 1156-1168

  Nikoletopoulou, Vassiliki ^a   Tavernarakis, Nektarios ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY AND BIOTECHNOLOGY   (Greece)

Author keywords

Embryonic stem cells; Induced pluripotent stem cells; Neuronal differentiation; Pluripotency

Indexed keywords

CELL LINES; DEVELOPMENTAL STAGE; EMBRYONIC STEM CELLS; EPIBLAST CELLS; EPIGENETIC ANALYSIS; GERM CELLS; HIGH-THROUGHPUT; HUMAN NEURONS; IN-VIVO; NEUROLOGICAL DISEASE; NEUROLOGICAL DISORDERS; NEURONAL DEVELOPMENT; NEURONAL DIFFERENTIATION; NEURONAL DYSFUNCTION; PLURIPOTENCY; PLURIPOTENT; PLURIPOTENT STEM CELLS; PRE-IMPLANTATION EMBRYOS; PRIMARY CULTURE; THERAPEUTIC INTERVENTION; VERSATILE TOOLS;

CELL CULTURE; NEUROLOGY; STEM CELLS;

NEURONS;

ACTIVIN; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; BONE MORPHOGENETIC PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 4; GLYCOGEN SYNTHASE KINASE 3BETA; LEUKEMIA INHIBITORY FACTOR; METHYL CPG BINDING PROTEIN 2; NERVE GROWTH FACTOR; NEUROGENIN 2; NEUROLEPTIC AGENT; PROTEIN P53; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; AUTISM; BLASTOCYST; BRAIN CELL; BRAIN DEVELOPMENT; CALLITHRIX; CELL CULTURE; CHIMERA; DNA METHYLATION; DOPAMINERGIC NERVE CELL; ECTODERM; EMBRYONIC STEM CELL; FRAGILE X SYNDROME; GABAERGIC SYSTEM; GENE EXPRESSION; HUMAN; MOTONEURON; MUTAGENESIS; NERVE CELL DIFFERENTIATION; NEUROBIOLOGY; NONHUMAN; PARKINSON DISEASE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RETT SYNDROME; REVIEW; RODENT; SCHIZOPHRENIA;

ANIMALS; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; HUMANS; MICE; NEUROBIOLOGY; PLURIPOTENT STEM CELLS; STEM CELL RESEARCH;

RODENTIA;

EID: 84866049231     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.201200040     Document Type: Review

References (132)

1. Evans, M. J., Kaufman, M. H., Establishment in culture of pluripotential cells from mouse embryos. Nature 1981, 292, 154-156.
2. Martin, G. R., Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 1981, 78, 7634-7638.
3. Brook, F. A., Gardner, R. L., The origin and efficient derivation of embryonic stem cells in the mouse. Proc. Natl. Acad. Sci. USA 1997, 94, 5709-5712.
4. Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W., Roder, J. C., Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl. Acad. Sci. USA 1993, 90, 8424-8428.
5. Smith, S. K., Charnock-Jones, D. S., Sharkey, A. M., The role of leukemia inhibitory factor and interleukin-6 in human reproduction. Hum. Reprod. 1998, 13, 237-246.
6. Niwa, H., Burdon, T., Chambers, I., Smith, A., Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes. Dev. 1998, 12, 2048-2060.
7. Escary, J. L., Perreau, J., Dumenil, D., Ezine, S., Brulet, P., Leukaemia inhibitory factor is necessary for maintenance of haematopoietic stem cells and thymocyte stimulation. Nature 1993, 363, 361-364.
8. Stewart, C. L., Kaspar, P., Brunet, L. J., Bhatt, H. et al., Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 1992, 359, 76-79.
9. Li, M., Sendtner, M., Smith, A., Essential function of LIF receptor in motor neurons. Nature 1995, 378, 724-727.
10. Ware, C. B., Horowitz, M. C., Renshaw, B. R., Hunt, J. S. et al., Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development 1995, 121, 1283-1299.
11. Kunath, T., Saba-El-Leil, M. K., Almousailleakh, M., Wray, J. et al., FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development 2007, 134, 2895-2902.
12. Ying, Q. L., Wray, J., Nichols, J., Batlle-Morera, L. et al., The ground state of embryonic stem cell self-renewal. Nature 2008, 453, 519-523.
13. Silva, J., Barrandon, O., Nichols, J., Kawaguchi, J. et al., Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol. 2008, 6, e253.
14. Nichols, J., Jones, K., Phillips, J. M., Newland, S. A. et al., Validated germline-competent embryonic stem cell lines from nonobese diabetic mice. Nat. Med. 2009, 15, 814-818.
15. Buehr, M., Meek, S., Blair, K., Yang, J. et al., Capture of authentic embryonic stem cells from rat blastocysts. Cell 2008, 135, 1287-1298.
16. Li, P., Tong, C., Mehrian-Shai, R., Jia, L. et al., Germline competent embryonic stem cells derived from rat blastocysts. Cell 2008, 135, 1299-1310.
17. Capecchi, M. R., Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century. Nat. Rev. Genet. 2005, 6, 507-512.
18. Blair, K., Wray, J., Smith, A., The liberation of embryonic stem cells. PLoS Genet. 2011, 7, e1002019.
19. Tong, C., Li, P., Wu, N. L., Yan, Y., Ying, Q. L., Production of p53 gene knockout rats by homologous recombination in embryonic stem cells. Nature 2010, 467, 211-213.
20. Meek, S., Buehr, M., Sutherland, L., Thomson, A. et al., Efficient gene targeting by homologous recombination in rat embryonic stem cells. PLoS One 2010, 5, e14225.
21. Thomson, J. A., Kalishman, J., Golos, T. G., Durning, M. et al., Isolation of a primate embryonic stem cell line. Proc. Natl. Acad. Sci. USA 1995, 92, 7844-7848.
22. Thomson, J. A., Kalishman, J., Golos, T. G., Durning, M. et al., Pluripotent cell lines derived from common marmoset (Callithrix jacchus) blastocysts. Biol. Reprod. 1996, 55, 254-259.
23. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A. et al., Embryonic stem cell lines derived from human blastocysts. Science 1998, 282, 1145-1147.
24. Roach, S., Cooper, S., Bennett, W., Pera, M. F., Cultured cell lines from human teratomas: windows into tumour growth and differentiation and early human development. Eur. Urol. 1993, 23, 82-88.
25. Braude, P. R., De Wert, G. M., Evers-Kiebooms, G., Pettigrew, R. A., Geraedts, J. P., Non-disclosure preimplantation genetic diagnosis for Huntington's disease: practical and ethical dilemmas. Prenatal Diag. 1998, 18, 1422-1426.
26. Brons, I. G., Smithers, L. E., Trotter, M. W., Rugg-Gunn, P. et al., Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 2007, 448, 191-195.
27. Tesar, P. J., Chenoweth, J. G., Brook, F. A., Davies, T. J. et al., New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 2007, 448, 196-199.
28. Guo, J., Li, Z. C., Feng, Y. H., Expression and activation of the reprogramming transcription factors. Biochem. Biophys. Res. Commun. 2009, 390, 1081-1086.
29. Eiges, R., Schuldiner, M., Drukker, M., Yanuka, O. et al., Establishment of human embryonic stem cell-transfected clones carrying a marker for undifferentiated cells. Curr. Biol. 2001, 11, 514-518.
30. Gropp, M., Itsykson, P., Singer, O., Ben-Hur, T. et al., Stable genetic modification of human embryonic stem cells by lentiviral vectors. Mol. Ther. 2003, 7, 281-287.
31. Ma, Y., Ramezani, A., Lewis, R., Hawley, R. G., Thomson, J. A., High-level sustained transgene expression in human embryonic stem cells using lentiviral vectors. Stem Cells 2003, 21, 111-117.
32. Zwaka, T. P., Thomson, J. A., Homologous recombination in human embryonic stem cells. Nat. Biotechnol. 2003, 21, 319-321.
33. Takahashi, K., Yamanaka, S., Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126, 663-676.
34. Maherali, N., Ahfeldt, T., Rigamonti, A., Utikal, J. et al., A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 2008, 3, 340-345.
35. Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T., Yamanaka, S., Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008, 322, 949-953.
36. Wernig, M., Lengner, C. J., Hanna, J., Lodato, M. A. et al., A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat. Biotechnol. 2008, 26, 916-924.
37. Mikkelsen, T. S., Hanna, J., Zhang, X., Ku, M. et al., Dissecting direct reprogramming through integrative genomic analysis. Nature 2008, 454, 49-55.
38. Hanna, J., Cheng, A. W., Saha, K., Kim, J. et al., Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc. Natl. Acad. Sci. USA 2010, 107, 9222-9227.
39. Kim, J. B., Zaehres, H., Arauzo-Bravo, M. J., Scholer, H. R., Generation of induced pluripotent stem cells from neural stem cells. Nat. Protoc. 2009, 4, 1464-1470.
40. Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J. et al., Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318, 1917-1920.
41. Stadtfeld, M., Brennand, K., Hochedlinger, K., Reprogramming of pancreatic beta cells into induced pluripotent stem cells. Curr. Biol. 2008, 18, 890-894.
42. Aoi, T., Yae, K., Nakagawa, M., Ichisaka, T. et al., Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 2008, 321, 699-702.
43. Hanna, J., Markoulaki, S., Schorderet, P., Carey, B. W. et al., Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 2008, 133, 250-264.
44. Eminli, S., Utikal, J., Arnold, K., Jaenisch, R., Hochedlinger, K., Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression. Stem Cells 2008, 26, 2467-2474.
45. Shi, Y., Do, J. T., Desponts, C., Hahm, H. S. et al., A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2008, 2, 525-528.
46. Chang, M. Y., Kim, D., Kim, C. H., Kang, H. C. et al., Direct reprogramming of rat neural precursor cells and fibroblasts into pluripotent stem cells. PLoS One 2010, 5, e9838.
47. Lowry, W. E., Richter, L., Yachechko, R., Pyle, A. D. et al., Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl. Acad. Sci. USA 2008, 105, 2883-2888.
48. Park, I. H., Lerou, P. H., Zhao, R., Huo, H., Daley, G. Q., Generation of human-induced pluripotent stem cells. Nat. Protoc. 2008, 3, 1180-1186.
49. Aasen, T., Raya, A., Barrero, M. J., Garreta, E. et al., Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol. 2008, 26, 1276-1284.
50. Hester, M. E., Song, S., Miranda, C. J., Eagle, A. et al., Two factor reprogramming of human neural stem cells into pluripotency. PLoS One 2009, 4, e7044.
51. Mochiduki, Y., Okita, K., Methods for iPS cell generation for basic research and clinical applications. Biotechnol. J. 2012, 7, 789-797.
52. Pandian, G. N., Sugiyama, H., Programmable genetic switches to control transcriptional machinery of pluripotency. Biotechnol. J. 2012, 7, 798-809.
53. Hawley, S. H., Wunnenberg-Stapleton, K., Hashimoto, C., Laurent, M. N. et al., Disruption of BMP signals in embryonic Xenopus ectoderm leads to direct neural induction. Genes. Dev. 1995, 9, 2923-2935.
54. Hemmati-Brivanlou, A., Melton, D., Vertebrate embryonic cells will become nerve cells unless told otherwise. Cell 1997, 88, 13-17.
55. Wiles, M. V., Johansson, B. M., Embryonic stem cell development in a chemically defined medium. Exp. Cell. Res. 1999, 247, 241-248.
56. Wilson, P. A., Hemmati-Brivanlou, A., Induction of epidermis and inhibition of neural fate by Bmp-4. Nature 1995, 376, 331-333.
57. Bain, G., Kitchens, D., Yao, M., Huettner, J. E., Gottlieb, D. I., Embryonic stem cells express neuronal properties in vitro. Dev. Biol. 1995, 168, 342-357.
58. Strubing, C., Ahnert-Hilger, G., Shan, J., Wiedenmann, B. et al., Differentiation of pluripotent embryonic stem cells into the neuronal lineage in vitro gives rise to mature inhibitory and excitatory neurons. Mech. Dev. 1995, 53, 275-287.
59. Fraichard, A., Chassande, O., Bilbaut, G., Dehay, C. et al., In vitro differentiation of embryonic stem cells into glial cells and functional neurons. J. Cell. Sci. 1995, 108, 3181-3188.
60. Liu, S., Qu, Y., Stewart, T. J., Howard, M. J. et al., Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc. Natl. Acad. Sci. USA 2000, 97, 6126-6131.
61. Schuldiner, M., Yanuka, O., Itskovitz-Eldor, J., Melton, D. A., Benvenisty, N., Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc. Natl. Acad. Sci. USA 2000, 97, 11307-11312.
62. Schuldiner, M., Eiges, R., Eden, A., Yanuka, O. et al., Induced neuronal differentiation of human embryonic stem cells. Brain Res. 2001, 913, 201-205.
63. Okabe, S., Forsberg-Nilsson, K., Spiro, A. C., Segal, M., McKay, R. D., Development of neuronal precursor cells and functional postmitotic neurons from embryonic stem cells in vitro. Mech. Dev. 1996, 59, 89-102.
64. Chen, E. Y., Wang, Y. C., Mintz, A., Richards, A. et al., Activated charcoal composite biomaterial promotes human embryonic stem cell differentiation toward neuronal lineage. J. Biomed. Mater. Res. A 2012, 100, 2006-2017.
65. Wang, J., Ye, R., Wei, Y., Wang, H. et al., The effects of electrospun TSF nanofiber diameter and alignment on neuronal differentiation of human embryonic stem cells. J. Biomed. Mater. Res. A 2012, 100, 632-645.
66. Lee, S. H., Lumelsky, N., Studer, L., Auerbach, J. M., McKay, R. D., Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat. Biotechnol. 2000, 18, 675-679.
67. Ye, W., Shimamura, K., Rubenstein, J. L., Hynes, M. A., Rosenthal, A., FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate. Cell 1998, 93, 755-766.
68. Kawasaki, H., Mizuseki, K., Nishikawa, S., Kaneko, S. et al., Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 2000, 28, 31-40.
69. Schulz, T. C., Palmarini, G. M., Noggle, S. A., Weiler, D. A. et al., Directed neuronal differentiation of human embryonic stem cells. BMC Neurosci. 2003, 4, 27.
70. Schulz, T. C., Noggle, S. A., Palmarini, G. M., Weiler, D. A. et al., Differentiation of human embryonic stem cells to dopaminergic neurons in serum-free suspension culture. Stem Cells 2004, 22, 1218-1238.
71. Perrier, A. L., Tabar, V., Barberi, T., Rubio, M. E. et al., Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc. Natl. Acad. Sci. USA 2004, 101, 12543-12548.
72. Kriks, S., Shim, J. W., Piao, J. H., Ganat, Y. M. et al., Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 2011, 480, 547-551.
73. Xi, J., Liu, Y., Liu, H., Chen, H. et al., Specification of midbrain dopamine neurons from primate pluripotent stem cells. Stem Cells 2012, DOI: 10.1002/stem.1152.
74. Wichterle, H., Lieberam, I., Porter, J. A., Jessell, T. M., Directed differentiation of embryonic stem cells into motor neurons. Cell 2002, 110, 385-397.
75. Peljto, M., Dasen, J. S., Mazzoni, E. O., Jessell, T. M., Wichterle, H., Functional diversity of ESC-derived motor neuron subtypes revealed through intraspinal transplantation. Cell Stem Cell 2010, 7, 355-366.
76. Sharma, K., Sheng, H. Z., Lettieri, K., Li, H. et al., LIM homeodomain factors Lhx3 and Lhx4 assign subtype identities for motor neurons. Cell 1998, 95, 817-828.
77. Dasen, J. S., De Camilli, A., Wang, B., Tucker, P. W., Jessell, T. M., Hox repertoires for motor neuron diversity and connectivity gated by a single accessory factor, FoxP1. Cell 2008, 134, 304-316.
78. Soundararajan, P., Miles, G. B., Rubin, L. L., Brownstone, R. M., Rafuse, V. F., Motoneurons derived from embryonic stem cells express transcription factors and develop phenotypes characteristic of medial motor column neurons. J. Neurosci. 2006, 26, 3256-3268.
79. Peljto, M., Wichterle, H., Programming embryonic stem cells to neuronal subtypes. Curr. Opin. Neurobiol. 2011, 21, 43-51.
80. Lee, H., Shamy, G. A., Elkabetz, Y., Schofield, C. M. et al., Directed differentiation and transplantation of human embryonic stem cell-derived motoneurons. Stem Cells 2007, 25, 1931-1939.
81. Li, X. J., Du, Z. W., Zarnowska, E. D., Pankratz, M. et al., Specification of motoneurons from human embryonic stem cells. Nat. Biotechnol. 2005, 23, 215-221.
82. Karumbayaram, S., Novitch, B. G., Patterson, M., Umbach, J. A. et al., Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells 2009, 27, 806-811.
83. Heins, N., Malatesta, P., Cecconi, F., Nakafuku, M. et al., Glial cells generate neurons: the role of the transcription factor Pax6. Nat. Neurosci. 2002, 5, 308-315.
84. Georgala, P. A., Carr, C. B., Price, D. J., The role of Pax6 in forebrain development. Dev. Neurobiol. 2011, 71, 690-709.
85. Ying, Q. L., Stavridis, M., Griffiths, D., Li, M., Smith, A., Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture. Nat. Biotechnol. 2003, 21, 183-186.
86. Conti, L., Pollard, S. M., Gorba, T., Reitano, E. et al., Niche-independent symmetrical self-renewal of a mammalian tissue stem cell. PLoS Biol. 2005, 3, e283.
87. Reynolds, B. A., Tetzlaff, W., Weiss, S., A multipotent EGF-responsive striatal embryonic progenitor cell produces neurons and astrocytes. J. Neurosci. 1992, 12, 4565-4574.
88. Watanabe, K., Kamiya, D., Nishiyama, A., Katayama, T. et al., Directed differentiation of telencephalic precursors from embryonic stem cells. Nat. Neurosci. 2005, 8, 288-296.
89. Bibel, M., Richter, J., Lacroix, E., Barde, Y. A., Generation of a defined and uniform population of CNS progenitors and neurons from mouse embryonic stem cells. Nat. Protoc. 2007, 2, 1034-1043.
90. Bibel, M., Richter, J., Schrenk, K., Tucker, K. L. et al., Differentiation of mouse embryonic stem cells into a defined neuronal lineage. Nat. Neurosci. 2004, 7, 1003-1009.
91. Thoma, E. C., Wischmeyer, E., Offen, N., Maurus, K. et al., Ectopic expression of neurogenin 2 alone is sufficient to induce differentiation of embryonic stem cells into mature neurons. PLoS One 2012, 7, e38651.
92. Chambers, S. M., Fasano, C. A., Papapetrou, E. P., Tomishima, M. et al., Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 2009, 27, 275-280.
93. Shi, Y., Kirwan, P., Smith, J., Robinson, H. P., Livesey, F. J., Human cerebral cortex development from pluripotent stem cells to functional excitatory synapses. Nat. Neurosci. 2012, 15, 477-486, S471.
94. Nikoletopoulou, V., Lickert, H., Frade, J. M., Rencurel, C. et al., Neurotrophin receptors TrkA and TrkC cause neuronal death whereas TrkB does not. Nature 2010, 467, 59-63.
95. Mohn, F., Weber, M., Rebhan, M., Roloff, T. C. et al., Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. Mol. Cell 2008, 30, 755-766.
96. Tiwari, V. K., Burger, L., Nikoletopoulou, V., Deogracias, R. et al., Target genes of Topoisomerase IIbeta regulate neuronal survival and are defined by their chromatin state. Proc. Natl. Acad. Sci. USA 2012, 109, E934-943.
97. Pasini, D., Bracken, A. P., Hansen, J. B., Capillo, M., Helin, K., The polycomb group protein Suz12 is required for embryonic stem cell differentiation. Mol. Cell. Biol. 2007, 27, 3769-3779.
98. Mitchell, K. J., The genetics of neurodevelopmental disease. Curr. Opin. Neurobiol. 2011, 21, 197-203.
99. Chen, S. J., Chang, C. M., Tsai, S. K., Chang, Y. L. et al., Functional improvement of focal cerebral ischemia injury by subdural transplantation of induced pluripotent stem cells with fibrin glue. Stem Cells Dev. 2010, 19, 1757-1767.
100. Cheung, A. Y., Horvath, L. M., Grafodatskaya, D., Pasceri, P. et al., Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation. Hum. Mol. Genet. 2011, 20, 2103-2115.
101. Chen, R. Z., Akbarian, S., Tudor, M., Jaenisch, R., Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat. Genet. 2001, 27, 327-331.
102. Marchetto, M. C., Carromeu, C., Acab, A., Yu, D. et al., A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 2010, 143, 527-539.
103. Tropea, D., Giacometti, E., Wilson, N. R., Beard, C. et al., Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice. Proc. Natl. Acad. Sci. USA 2009, 106, 2029-2034.
104. Muotri, A. R., Marchetto, M. C., Coufal, N. G., Oefner, R. et al., L1 retrotransposition in neurons is modulated by MeCP2. Nature 2010, 468, 443-446.
105. Coffee, B., Zhang, F., Warren, S. T., Reines, D., Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. Nat. Genet. 1999, 22, 98-101.
106. Oberle, I., Rousseau, F., Heitz, D., Kretz, C. et al., Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 1991, 252, 1097-1102.
107. Eiges, R., Urbach, A., Malcov, M., Frumkin, T. et al., Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell 2007, 1, 568-577.
108. Urbach, A., Bar-Nur, O., Daley, G. Q., Benvenisty, N., Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell 2010, 6, 407-411.
109. Koenen, K. C., Moffitt, T. E., Roberts, A. L., Martin, L. T. et al., Childhood IQ and adult mental disorders: a test of the cognitive reserve hypothesis. Am. J. Psychiatry 2009, 166, 50-57.
110. Chiang, C. H., Su, Y., Wen, Z., Yoritomo, N. et al., Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation. Mol. Psychiatry 2011, 16, 358-360.
111. Brennand, K. J., Simone, A., Jou, J., Gelboin-Burkhart, C. et al., Modelling schizophrenia using human induced pluripotent stem cells. Nature 2011, 473, 221-225.
112. Ebert, A. D., Yu, J., Rose, F. F. Jr., Mattis, V. B. et al., Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009, 457, 277-280.
113. Han, S. S., Williams, L. A., Eggan, K. C., Constructing and deconstructing stem cell models of neurological disease. Neuron 2011, 70, 626-644.
114. Saporta, M. A., Grskovic, M., Dimos, J. T., Induced pluripotent stem cells in the study of neurological diseases. Stem Cell Res. Ther. 2011, 2, 37.
115. Hargus, G., Cooper, O., Deleidi, M., Levy, A. et al., Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc. Natl. Acad. Sci. USA 2010, 107, 15921-15926.
116. Soldner, F., Hockemeyer, D., Beard, C., Gao, Q. et al., Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009, 136, 964-977.
117. Nguyen, H. N., Byers, B., Cord, B., Shcheglovitov, A. et al., LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell 2011, 8, 267-280.
118. Pu, J., Jiang, H., Zhang, B., Feng, J., Redefining Parkinson's disease research using induced pluripotent stem cells. Curr. Neurol. Neurosci. Rep. 2012, 12, 392-398.
119. Seibler, P., Graziotto, J., Jeong, H., Simunovic, F. et al., Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells. J. Neurosci. 2011, 31, 5970-5976.
120. Park, I. H., Arora, N., Huo, H., Maherali, N. et al., Disease-specific induced pluripotent stem cells. Cell 2008, 134, 877-886.
121. Yahata, N., Asai, M., Kitaoka, S., Takahashi, K. et al., Anti-Abeta drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer's disease. PLoS One 2011, 6, e25788.
122. Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A. et al., Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362, 59-62.
123. Nishimura, A. L., Mitne-Neto, M., Silva, H. C., Richieri-Costa, A. et al., A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am. J. Hum. Genet. 2004, 75, 822-831.
124. Dimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M. et al., Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008, 321, 1218-1221.
125. Mitne-Neto, M., Machado-Costa, M., Marchetto, M. C., Bengtson, M. H. et al., Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients. Hum. Mol. Genet. 2011, 20, 3642-3652.
126. Anagnostou, G., Akbar, M. T., Paul, P., Angelinetta, C. et al., Vesicle associated membrane protein B (VAPB) is decreased in ALS spinal cord. Neurobiol. Aging 2010, 31, 969-985.
127. Clement, A. M., Nguyen, M. D., Roberts, E. A., Garcia, M. L. et al., Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 2003, 302, 113-117.
128. Di Giorgio, F. P., Boulting, G. L., Bobrowicz, S., Eggan, K. C., Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell 2008, 3, 637-648.
129. Nagai, M., Re, D. B., Nagata, T., Chalazonitis, A. et al., Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci. 2007, 10, 615-622.
130. Marchetto, M. C., Muotri, A. R., Mu, Y., Smith, A. M. et al., Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. Cell Stem Cell 2008, 3, 649-657.
131. Pera, M. F., Andrade, J., Houssami, S., Reubinoff, B. et al., Regulation of human embryonic stem cell differentiation by BMP-2 and its antagonist noggin. J. Cell Sci. 2004, 117, 1269-1280.
132. Yan, Y., Yang, D., Zarnowska, E. D., Du, Z. et al., Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells 2005, 23, 781-790.